LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -0.96%309M | 105M | -1.09%91M | -41.54%114M | -104.00%-1M | -58.23%312M | 0 | -60.52%92M | -25.00%195M | -90.74%25M |
Net income from continuing operations | -80.83%60M | -61.76%26M | -65.22%32M | -95.00%4M | -102.74%-2M | -11.08%313M | -12.82%68M | -38.67%92M | 9.59%80M | 43.14%73M |
Operating gains losses | -150.00%-2M | ---- | 400.00%6M | -175.00%-3M | -66.67%-5M | 130.77%4M | 225.00%5M | 0.00%-2M | 200.00%4M | 0.00%-3M |
Depreciation and amortization | 25.82%268M | 22.81%70M | 28.30%68M | 30.77%68M | 21.57%62M | -12.70%213M | -9.52%57M | -7.02%53M | -18.75%52M | -15.00%51M |
Deferred tax | -26.09%-29M | ---29M | ---- | ---- | ---- | 39.47%-23M | ---- | ---- | ---- | ---- |
Other non cash items | -312.50%-33M | -6,800.00%-67M | 200.00%13M | --24M | -175.00%-3M | -117.02%-8M | -93.75%1M | -360.00%-13M | --0 | -63.64%4M |
Change In working capital | 4.99%-381M | 95.73%-7M | -60.42%-154M | -4,550.00%-93M | 8.63%-127M | -702.00%-401M | 15.46%-164M | -336.36%-96M | -103.33%-2M | -231.13%-139M |
-Change in receivables | -11.15%-339M | 52.73%-78M | -14.29%-80M | -135.19%-127M | -237.50%-54M | 23.94%-305M | 15.82%-165M | 12.50%-70M | -671.43%-54M | 86.44%-16M |
-Change in inventory | -21.88%-78M | -48.15%-40M | -123.33%-7M | -117.65%-6M | 75.25%-25M | -164.00%-64M | -2,600.00%-27M | -62.96%30M | 666.67%34M | -488.46%-101M |
-Change in payables and accrued expense | 124.42%21M | 718.18%68M | 4.67%-102M | 36.54%-33M | 4.76%88M | -129.25%-86M | -129.73%-11M | -224.24%-107M | ---52M | -71.03%84M |
-Change in other current assets | 0.00%-8M | -96.61%2M | 114.93%144M | -17.27%91M | -0.41%-245M | 76.47%-8M | 553.85%59M | -51.45%67M | 4.76%110M | 7.58%-244M |
-Change in other working capital | -62.90%23M | 305.00%41M | -581.25%-109M | 55.00%-18M | -21.01%109M | 788.89%62M | 4.76%-20M | 87.50%-16M | -25.00%-40M | -19.77%138M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -0.96%309M | --105M | -1.09%91M | -41.75%113M | --0 | -58.23%312M | --0 | -60.52%92M | -25.38%194M | -90.37%26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -894.30%-1.57B | 48.65%-57M | -45.45%-32M | 35.71%-9M | -13,290.91%-1.47B | -62.89%-158M | -141.30%-111M | -37.50%-22M | 33.33%-14M | 21.43%-11M |
Capital expenditure reported | -68.00%-126M | -103.57%-57M | -45.45%-32M | -28.57%-18M | -72.73%-19M | 22.68%-75M | 39.13%-28M | -37.50%-22M | 33.33%-14M | 21.43%-11M |
Net business purchase and sale | -1,825.33%-1.44B | --0 | --0 | --10M | ---1.45B | ---75M | ---75M | --0 | --0 | --0 |
Net other investing changes | 87.50%-1M | ---- | --0 | ---- | ---- | ---8M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -894.30%-1.57B | 48.65%-57M | -45.45%-32M | 35.71%-9M | -13,290.91%-1.47B | -62.89%-158M | -141.30%-111M | -37.50%-22M | 33.33%-14M | 21.43%-11M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 531.69%1.16B | -59.16%185M | -10.17%-130M | 48.81%-172M | 591.85%1.27B | 123.40%183M | 428.26%453M | 6.35%-118M | 12.73%-336M | 238.35%184M |
Net issuance payments of debt | 197.67%1.66B | -42.29%318M | 68.63%-16M | 70.78%-64M | 412.95%1.43B | 213.16%559M | 1,877.42%551M | -41.67%-51M | 27.48%-219M | 322.40%278M |
Net common stock issuance | -17.39%-432M | -25.00%-125M | -74.19%-108M | 17.36%-100M | -16.47%-99M | -35.29%-368M | 9.09%-100M | 26.19%-62M | -55.13%-121M | ---85M |
Proceeds from stock option exercised by employees | 11.76%19M | 75.00%7M | --0 | 0.00%6M | 20.00%6M | 142.86%17M | 0.00%4M | --2M | 200.00%6M | 400.00%5M |
Net other financing activities | -280.00%-95M | -650.00%-15M | 14.29%-6M | -1,200.00%-13M | -306.67%-61M | -8.70%-25M | -100.00%-2M | -16.67%-7M | 85.71%-1M | -66.67%-15M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 531.69%1.16B | -59.16%185M | -10.17%-130M | 48.96%-171M | 595.08%1.27B | 123.40%183M | 428.26%453M | 6.35%-118M | 12.99%-335M | 237.59%183M |
Net cash flow | ||||||||||
Beginning cash position | 59.46%885M | 1.12%541M | 2.21%601M | -9.84%678M | 59.46%885M | -20.14%555M | -28.09%535M | -11.71%588M | -7.96%752M | -20.14%555M |
Current changes in cash | -131.45%-106M | -31.87%233M | -47.92%-71M | 56.77%-67M | -201.52%-201M | 355.30%337M | 271.00%342M | -152.75%-48M | -6.16%-155M | 60.98%198M |
Effect of exchange rate changes | -85.71%-13M | -200.00%-8M | 320.00%11M | -11.11%-10M | -500.00%-6M | 12.50%-7M | -27.27%8M | 61.54%-5M | -80.00%-9M | 0.00%-1M |
End cash Position | -13.45%766M | -13.45%766M | 1.12%541M | 2.21%601M | -9.84%678M | 59.46%885M | 59.46%885M | -28.09%535M | -11.71%588M | -7.96%752M |
Free cash flow | -22.78%183M | 271.43%48M | -15.71%59M | -47.22%95M | -226.67%-19M | -63.54%237M | 54.84%-28M | -67.74%70M | -24.69%180M | -94.14%15M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |